Works Ministry: Speed limit on federal roads reduced to 80km/h during Aidilfitri period

Works Ministry: Speed limit on federal roads reduced to 80km/h during Aidilfitri period

KUALA LUMPUR, April 2 — The Works Ministry (KKR) has announced a temporary reduction in speed limit on federal roads nationwide by 10km/h from April 8 to 14 in conjunction with the Hari Raya Aidilfitri celebration. In a statement today, KKR said that the speed limit on federal roads will be lowered from 90 km/h … Read more

Najib’s reduced sentence may damage Malaysia’s global image, lawyers’ group warns

Najib’s reduced sentence may damage Malaysia’s global image, lawyers’ group warns

KUALA LUMPUR, Feb 3 — The reduction in former prime minister Datuk Seri Najib Razak’s sentence will damage Malaysia’s international standing and image, Lawyers for Liberty said today. Its director Zaid Malek said in a statement this is because the 1MDB corruption scandal was a global news event that involved corrupt transactions in multiple countries. … Read more

Groundwater levels are being significantly reduced, but depletion isn’t irreversible

Groundwater levels are being significantly reduced, but depletion isn’t irreversible

PARIS, Jan 30 — The level of groundwater in aquifers has been declining dramatically worldwide since the 1980s, as one of the most extensive studies on the subject has shown. But the good news is that it is possible to reverse the trend. With the water crisis intensifying in many areas around the world, there … Read more

Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors

Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors

In the Phase III NETTER-2 trial, Lutathera plus octreotide LAR significantly extended median PFS to 22.8 months vs. 8.5 months with high-dose octreotide LAR in patients with newly diagnosed grade 2 and 3 advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)1 NETTER-2 is the first and only positive Phase III trial for a radioligand therapy (RLT) in the … Read more